Stocktoria
SELLAS Life Sciences Group, Inc. SLS
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2008-03-12
SELLAS Life Sciences Group, Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Stergiou Angelos M. | President and CEO | 2026-06-16 | Grant | 1,065,000 | — |
| Varian John | director | 2026-01-07 | Grant | 50,000 | — |
| VAN NOSTRAND ROBERT L | director | 2026-01-07 | Grant | 50,000 | — |
| SCHEINBERG DAVID A | director | 2026-01-07 | Grant | 50,000 | — |
| CICIC DRAGAN | SVP, Chief Development Officer | 2026-01-07 | Grant | 300,000 | — |
| Burns John Thomas | CFO | 2026-01-07 | Grant | 300,000 | — |
| Kalin Katherine Bach | director | 2026-01-07 | Grant | 50,000 | — |
| Wasman Jane | director | 2026-01-07 | Grant | 50,000 | — |
Source: SEC EDGAR filings · CIK 0001390478 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.